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ABSTRACT
The bone morphogenetic proteins (BMPs) play fundamental roles during the organization of the 
central nervous system. The presence of these proteins has also been demonstrated in regions of the 
adult brain that are characterized by neural plasticity. In this study, we examined the expression of 
BMP4, 6, and 7 mRNAs and proteins in the murine olfactory system. The olfactory system is a 
useful model for studying cell proliferation and neural differentiation because both of these 
processes persist throughout life in the olfactory epithelium (OE) and olfactory bulb (OB). Our 
results demonstrate a differential expression of BMP4, 6, and 7 in the embryonic, postnatal, and 
adult olfactory system. In particular, BMP4 and BMP7 showed similar immunostaining patterns, 
being expressed in the olfactory region from the earliest stages studied (embryonic day 15.5) to 
adulthood. During development BMPs were expressed in the OE, olfactory bulb nerve layer, 
glomerular layer (GL), mitral cell layer (MCL), and subventricular zone. During the first postnatal 
week of life, BMP4 and 7immunoreactivity (-ir) was particularly evident in the GL, MCL, and in 
the subependymal layer (SEL), which originates postnatally from the subventricular zone. In adults,
BMP4 and 7 immunostaining was present in the GL and SEL. Within the SEL, BMP4 and 7 
proteins were expressed primarily in association with the astrocytic glial compartment. BMP6-ir 
was always found in mature olfactory receptor neurons and their axonal projections to the OB. In 
summary, these data support the hypothesis that BMPs play a role in the morphogenesis of the 
olfactory system during development and in its plasticity during adulthood. 
Indexing terms: neural plasticity; olfactory glomerulus; subventricular zone; transforming 
growth-factor-β
The bone morphogenetic proteins (BMPs) are a subclass of ligands that are members of the 
transforming growth factor-β (TGFβ ) superfamily of cytokines. This large group of molecules 
includes more than 20 members, which participate in a multitude of biological processes. BMPs 
exert their biological function by interacting with serine/threonine kinase receptors, including BMP 
receptor type-I and type-II (BMPR-I and II). They play important roles throughout neural 
development, acting in cell proliferation, survival, lineage commitment, apoptosis, and 
differentiation. In early embryogenesis BMPs together with BMP-related factors, such as their 
natural antagonists/modulators noggin, chordin, tolloid, and follistatin, are involved in neurulation 
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and in subsequent dorsoventral patterning within the neural tube (Hogan, 1996; Dale et al., 1999; 
Bachiller et al., 2000). Later during development, BMPs play instructive and inductive roles in 
lineage elaboration within the peripheral and central nervous system (Mehler et al. 1997). The 
expression of BMPs and their receptors has been demonstrated within the embryonic germinal 
ventricular (VZ) and subventricular (SVZ) zones of the brain. In vivo and in vitro studies have 
shown that the undifferentiated precursor cells of the VZ and SVZ exhibit temporal and site-specific
responsiveness to different members of the BMPs (Gross et al., 1996; Li et al., 1998; Mabie et al., 
1999; Mehler et al., 2000). BMPs are also implicated in regional neuronal survival (Mehler et al., 
1997; Shou et al., 1999), induction and maintenance of specific neuronal phenotypes (Lopez-
Coviella et al., 2000), dendritic growth (Le Roux et al., 1999; Withers et al., 2000), and gap 
junctional communication (Bani Yaghoub et al., 2000). Furthermore, several reports suggest a role 
for these cytokines in neural plasticity. Transcripts for BMP type-I and type-II receptors are 
upregulated in neurons of the dentate gyrus after cortical injury in the same hemisphere (Ebendal et 
al., 1998), and sympathetic, hippocampal, and cerebral cortical neurons exposed to BMP7 in vitro 
exhibited enhanced dendritic growth without altering rates of cell survival (Lein et al., 1995; Le 
Roux et al., 1999; Withers et al., 2000). Taken together, these results demonstrate the involvement 
of BMPs in the development and differentiation of many cell types in the nervous system.
The aim of this study was to investigate the presence of BMP4, 6, and 7 in the developing and adult 
murine olfactory system. In rodents, the olfactory epithelium (OE) and olfactory bulb (OB) begin 
developing during the prenatal period. Morphologic and functional maturity of the OE and OB is 
reached during the first postnatal weeks, and a high degree of neural plasticity is retained in these 
regions into adulthood. Indeed, it is well known that, in the OE and OB of rodents, neurogenesis 
persists throughout life (Altman, 1969; Bayer, 1983; Brunjes and Frazier, 1986). The olfactory 
receptor neurons (ORNs) are capable of being replaced as a consequence of the mitotic activity of 
undifferentiated precursor cells located in the basal layers of the OE (Thornhill, 1970; Graziadei 
and Metcalf, 1971; Graziadei and Monti Graziadei, 1979; Calof et al., 1998). The ORNs project 
their axons to the OB, where they establish synapses with the dendrites of mitral/tufted and 
juxtaglomerular cells in regions of neuropil called OB glomeruli. The replacement of ORNs can 
lead to reorganization of the neural circuits within the OB glomeruli (Graziadei and Monti 
Graziadei, 1978).
Recently, cell renewal occurring in the adult OB of rodents has been related to the migration of 
newly generated cells from the forebrain subependymal layer (SEL) (Luskin, 1993; Lois and 
Alvarez-Buylla, 1994). The SEL consists of a remnant of the embryonic subventricular zone that 
persists in the adult forebrain (Boulder Committee, 1970). In rodents, the newly formed cells 
migrate to the OB as immature elements along the SEL, within a channel system of astrocytic glial 
cells and processes called glial tubes (Lois et al., 1996; Peretto et al., 1997). After arrival in the OB, 
the SEL neuroblasts differentiate into granule and periglomerular cells (Luskin, 1993; Lois and 
Alvarez-Buylla, 1994; Alvarez-Buylla et al., 2000).
Previous studies demonstrated that in cultures of embryonic OE, BMPs exert both positive and 
negative concentration-dependent effects on neurogenesis. Thus, high levels of BMP2, 4, and 7 
inhibit neurogenesis, whereas low levels of BMP4 promote ORN survival. In addition, ligand-
specific activity has been reported, e.g., BMP4 blocks the activity of noggin. Because noggin 
inhibits neurogenesis in this model, exogenous BMP4 results in an enhancement of neurogenesis in 
OE cultures (Shou et al., 1999, 2000). In addition, in vivo studies of the mouse
OB during neonatal development have shown that mitral cells express BMPR-I and -II mRNA 
(Zhang et al., 1998). Finally, the abundant expression of several BMPs and their receptors has been 
reported in the OB and hippocampus of adult rat and mouse (Charytoniuk et al., 2000). These 
observations indicate that the expression of BMPs and/or related factors is maintained in regions of 
the postnatal and adult nervous systems that are characterized by continuing neural plasticity. The 
involvement of these proteins in modulating central nervous system (CNS) plasticity is further 
confirmed by studies suggesting that BMPs and their natural antagonist, noggin, participate in the 
regulation of neurogenesis of adult OB interneurons (Coskun et al., 2001; Lim et al., 2000). Our 
results demonstrate a differential expression of BMP4, 6, and 7 in the embryonic, postnatal, and 
adult olfactory system. These data support the involvement of the BMPs in multiple actions that 




Olfactory bulbs and epithelia were dissected from CD-1 mice at specified ages and homogenized at 
4°C in 50 mM Tris-HCl, pH 7.5, containing 2 mM dithiothreitol, 0.2 mM phenylmethyl sulfonyl 
fluoride, 5 ␮μg/ml leupeptin, 10 ␮μg/ml aprotinin, and centrifuged at 100,000 x g for 1 hour. 
Protein concentration of the supernatants was determined by the Bradford method (Bio-Rad, 
Hercules, CA). Equal amounts of protein in denaturing sample-buffer were separated by sodium 
dodecyl sulfate (SDS) -polyacrylamide gel electrophoresis on 10 –20% ReadyGels (Bio-Rad) and 
electroblotted to Immobilon-P membranes (Millipore, Bedford, MA). Blocking was for 1 hour at 
room temperature or overnight at 4°C in 25 mM Tris-HCl, pH 7.4, 0.8% NaCl; 0.02% KCl, 0.05% 
Tween-20, and 1% bovine serum albumin (TBST/BSA). Western analyses were done with goat anti-
BMP4, BMP6, or BMP7 (1:500 in TBS-Tween-BSA solution; Santa Cruz Biotechnology, Inc., 
Santa Cruz, CA) for 1 hour at room temperature. Anti-BMP4 and 6 antibodies were directed against
peptides at the amino terminus of the BMP4 and BMP6, respectively. Anti-BMP7 was directed 
against a peptide corresponding to an amino acid sequence near the carboxyl terminus of BMP7. 
After multiple rinses in TBST/BSA, the membrane was incubated with horseradish peroxidase– 
conjugated donkey anti-goat antiserum (1:50,000 in TBST/BSA) for 1 hour at room temperature. 
Washes were in TBST and in TBS alone. The reaction was visualized with SuperSignal West Pico 
Chemiluminescent Substrate (Pierce, Rockford, IL), and images were collected on Kodak X-OMAT
film. Control reactions included (1) omission of primary antibodies, and (2) incubation of 
membranes in BMP antisera preabsorbed with 2 ␮μg/ml of their respective peptide (Santa Cruz 
Biotechnology, Inc.).
Tissue preparation
Embryos. Timed pregnant CD-1 female mice (the morning after coitus was E0.5) were deeply 
anesthetized with ketamine/xylazine (100 mg/kg body weight/33 mg/kg body weight), and embryos
were removed and perfused transcardially with ice-cold 0.9% NaCl followed by 4% 
paraformaldehyde in 0.1 M sodium phosphate buffer, pH 7.4 (PFA). Embryo heads were removed, 
post-fixed in 4% PFA for several hours to overnight, embedded in 10% gelatin/0.1 M sodium 
phosphate buffer, pH 7.4 (PB), and further fixed and cryoprotected in 2% PFA with 30% sucrose/PB
overnight at 4°C. Embedded tissue was then quick-frozen in cold isopentane (-70°C) and sectioned 
coronally on a cryostat at 35 ␮μm for immunohistochemistry. Embryos used for in situ 
hybridization were perfused as above, post-fixed in 4% PFA, cryoprotected in 30% sucrose/PB 
overnight at 4°C, quick-frozen and sectioned at 8 ␮μm. Sections for in situ hybridization (ISH) 
were mounted onto slides precoated with a 2% solution of 3-aminopropyltriethoxysilane and stored 
at -70°C until further processing (for details, see Schmale and Behrens, 1995).
Postnatal and adult stages. Brains and olfactory epithelia were obtained from CD-1 mice on 
postnatal days 2 (P2), P7, P14, P21, and adult. For each age group, data were analyzed from at least 
three different animals, including both sexes, from at least two different litters. Animals were deeply
anesthetized with ketamine/xylazine (100 mg/kg body weight / 33 mg/kg body weight) and then 
perfused transcardially with ice-cold 0.9% NaCl (1 to 7 minutes) followed by 4% buffered PFA (20 
to 100 ml). After dissection, brains and olfactory epithelia were post-fixed overnight at 4°C in the 
same fixative, cryoprotected in ascending sucrose solutions (7.5%, 15%, 30%), quick-frozen in cold
isopentane (-70°C), and sectioned on a cryostat for immunohistochemistry (10 ␮μm). Coronal 
sections were serially collected onto Superfrost Plus slides (Fisher, Pittsburgh, PA). All procedures 
involving animals were approved by the University of Maryland School of Medicine’s Institutional 
Animal Care and Use Committee.
Immunohistochemistry
Embryos. Sections were processed for conventional free-floating biotin-avidin system 
immunohistochemistry by using goat anti-BMP4, BMP6, or BMP7 (Santa Cruz Biotechnology, 
Inc.; dilutions: 1:100, 1:500, and 1:250, respectively) or goat anti-olfactory marker protein (OMP; 
dilution: 1:20,000; Keller and Margolis, 1975). Briefly, sections were incubated in 1% H2O2 in Tris 
buffered saline (TBS: 0.05 M Tris/HCl, pH 7.2, 0.25 M NaCl), to block endogenous peroxidases, 
rinsed in TBS, and transferred to blocking solution containing 0.1% gelatin, 5% normal horse serum
(Vector Laboratories, Inc.), and 0.5% Triton X-100. Sections were then incubated in primary anti-
serum diluted in TBS with 3% normal horse serum and 0.2% Triton X-100 overnight at 4°C. The 
next day, sections were rinsed in TBS, placed in biotinylated anti-goat secondary antiserum (1:200; 
Vector Laboratories, Inc.), rinsed, and incubated in avidin-biotin complex (ABC, 1:400; Vector 
Laboratories, Inc.). The reaction product was visualized with 0.15 mg/ml 3,3'-diaminobenzidine in 
TBS with 0.01% H2O2. Sections were then serially mounted onto Superfrost Plus slides (Fisher), 
air-dried, dehydrated in graded alcohols, cleared in xylenes, and cover-slipped by using D.P.X. 
mounting medium (Aldrich, Milwaukee, WI).
Postnatal and adult stages. In sections processed for conventional ABC immunohistochemistry on 
slides, the following primary antisera were used: goat anti-BMP4, BMP6, or BMP7 (dilutions: 
1:100, 1:100, and 1:150, respectively; Santa Cruz Biotechnology, Inc.). All incubations were run at 
room temperature. Briefly, sections were rinsed in 0.1 M sodium phosphate-buffered saline (PBS), 
pH 7.4, then incubated overnight with primary antibodies diluted in PBS containing 0.1% Triton X-
100 and 1% non-immune serum of the same donor species of the secondary antiserum. The next 
day, sections were rinsed in PBS and treated with biotinylated anti-goat secondary antiserum 
(1:200; Vector Laboratories, Inc.) for 1 hour, rinsed, and incubated in avidin-biotin complex (1:400; 
Vector Laboratories, Inc.) for 1 hour. After rinses in PBS and in 0.05 M TBS, pH 7.4, the reaction 
product was visualized with 0.15 mg/ml 3,3'-diaminobenzidine in TBS with 0.01% H2O2.
For dual immunofluorescence primary antibodies were used at the following concentrations: goat 
anti-BMP4, BMP6, or BMP7 (dilutions: 1:80, 1:60, and 1:80, respectively; Santa Cruz 
Biotechnology, Inc.); rabbit anti– glial fibrillary acidic protein (anti-GFAP; 1:500; DAKO 
Corporation, Carpinteria, CA); anti–PSA-NCAM (a monoclonal immunoglobulin [Ig] M antiserum 
raised against the capsular polysaccharides of meningococcus group B that share ␮α-2,8-PSA 
residues with PSA-NCAM; 1:1,000; generously provided by Dr. G. Rougon, University of 
Marseille); monoclonal IgG anti-growth associated protein 43 (anti-GAP43; 1:150; F. Hoffmann-La
Roche, Ltd., Basel, Switzerland); rabbit anti-olfactory marker protein (anti-OMP; 1:5,000; Keller 
and Margolis, 1975). Double labeling was carried out following the single-label protocol. Sections 
were incubated in primary antisera overnight, rinsed, and transferred to secondary antisera 
conjugated with either CY3 or biotin (diluted 1:800 and 1:200, respectively; Jackson 
ImmunoResearch Laboratories, Inc., West Grove, PA) for 90 minutes. When biotinylated secondary 
antisera were used, the sections were incubated in a tertiary streptavidin conjugated to CY2 (1:800; 
Jackson ImmunoResearch Laboratories, Inc.) for 1 hour. Sections were then cover-slipped with an 
anti-fade mounting medium (DAKO Corporation). Control reactions included (1) omission of the 
primary antibodies, and (2) incubation of sections in BMP antisera preabsorbed with 10 μM of the 
respective peptides.
In situ hybridization
Probe preparation. BMP4 was a 467-bp polymerase chain reaction fragment generated by using 5'-
CTGGGAAGAATCATGGACTG-3' as the forward and 5'-AAAGCAGACCTCTCACTGGT-3' as 
the reverse primers, and subcloned into pGEM-T. Linearization with ApaI or BstXI and 
transcription with T7 or Sp6 polymerases gave the sense or antisense digoxigenin (DIG) -11-UTP–
labeled riboprobes, respectively (Schmale and Behrens, 1995; Behrens et al., 2000). BMP6 was an 
893-bp EcoRI–SacI fragment cloned into pBS-SK generously provided by B. Hogan. Linearization 
with EcoRI or SacI and transcription with T3 or T7 polymerases gave the sense or anti-sense DIG-
11-UTP–labeled riboprobes, respectively, as above.
Tissue processing. The details of this procedure are exactly as described previously (Schmale and 
Behrens, 1995; Behrens et al., 2000) and are briefly summarized here. Sections were immersed in 
4% paraformaldehyde, 1x PBS, 1 mM MgCl2 (pH 7.2) for 5 minutes; rinsed with 1x PBS (pH 7.4); 
ultraviolet-crosslinked with an energy of 120 mJ/cm2; rinsed again with 1x PBS (pH 7.4). The tissue
was then treated with 0.2 M HCl for 10 minutes, with 1% Triton X-100 in 1x PBS (pH 7.4) for 2 
minutes, and acetylated in 0.1 M triethanolamine (pH 8.0), 0.25% acetic anhydride. After a brief 
rinse in 1x PBS (pH 7.4), sections were submerged in prehybridization buffer (50% formamide, 
0.75 M NaCl, 25 mM Pipes, 25 mM EDTA, 5x Denhardt’s reagent, 0.2% SDS, 250 μg/ml yeast 
tRNA, 250 μg/ml herring sperm DNA; pH 6.8) freshly heated to 85°C for 10 minutes and incubated
for 5 hours at 55°C in a humid chamber containing 50% formamide. Hybridization was done 
overnight at 55°C in a humid chamber with 50% formamide in hybridization buffer (25– 80 ng/ml 
DIG-labeled riboprobes, and 100 mg/ml dextran sulfate in pre-hybridization buffer freshly heated to
85°C for 10 minutes). Stringency washes were done as follows: 3 x 5 minutes 2x SSC at room 
temperature, 30 minutes RNAse-buffer (10 μg/ml RNAse A, 0.5 M NaCl, 10 mM Tris-HCl, 1 mM 
EDTA; pH 7.5) at 37°C, 15 minutes 0.4x SSC at room temperature, two times 0.4x SSC at 55°C. 
For immunohistochemical detection of DIG-labeled probes, the specimens were incubated at room 
temperature for 5 minutes in buffer 1 (150 mM NaCl, 100 mM maleic acid; pH 7.5), 60 minutes in 
buffer 1 containing 1% blocking reagent (Roche), 60 minutes in buffer 1 containing 1% blocking 
reagent, with 1:750 diluted anti–DIG-alkaline phosphatase, followed by two 30-minute washes in 
buffer 1. For colorimetric detection, slides were equilibrated in 100 mM Tris-HCl, 100 mM NaCl, 
50mM MgCl2; pH 9.5, and incubated in the same buffer containing 25 mg/ml 5-bromo-4-chloro-3-
indoxyl phosphate, and 50 mg/ml nitroblue tetrazolium overnight. After stopping the color reaction 
with TE-buffer, sections were mounted by using a water-based mounting medium (Dako fluorescent
mounting medium).
Preparation of Figures
Light photomicrographs were digitized by using a Phase One PowerPhase digital camera (Phase 
One, Denmark) fitted to a Leica DMRX microscope (Leica Microsystems Inc., Deerfield, IL). 
Analysis and digital photography of the double immunofluorescence was carried out by using a 
FluoView Olympus confocal microscope (Olympus, Melville, NJ) equipped with krypton and argon
ion lasers and standard excitation and emission filters for the visualization of CY2 and CY3. 
Double-labeling visualization was performed by combining the visualization of one chromogen 
with the visualization of the second antigen with a different chromogen. Digital images were 
adjusted linearly, cropped, and assembled in Adobe Photoshop (Adobe Systems, Inc., Mountain 
View, CA). Plates of photomicrographs were printed by using a Fuji Fujix Pictrography 3000 
printer (Fuji Photofilm USA, Carlstadt, NJ).
RESULTS
Western blot analysis
As an initial assessment of the presence of the BMPs in the olfactory system and to confirm the 
specificity of the antisera, extracts prepared from the OB and OE of post-natal and adult animals 
were immunoblotted with antibodies directed against BMP4, BMP6, or BMP7. The BMP4 antibody
resulted in a band of approximately 30 kDa both in OB and OE extracts (Fig. 1B). The BMP6 
antibody recognized a single band with a molecular weight of slightly less than 30 kDa. Protein 
preparations from animals at different ages (P10, P17, adult) revealed a gradual increase in the 
expression of BMP6 both in the
olfactory bulb and epithelium (Fig. 1A). The BMP7 antibody identified a major band of 
approximately 46 kDa (Fig. 1C). Preincubation of each antiserum with the appropriate 
immunogenic peptide (2 ␮g/ml) completely eliminated all immunoreactivity, confirming the 
specificity of these antisera.
Fig. 1. Western blot analysis of bone morphogenetic protein (BMP) expression during the postnatal development of the 
olfactory system. Mouse tissue extracts (A: 20 μg/lane; B: 34.5 μg/lane; C: 30 μg/lane;) were subjected to sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to nitrocellulose, and probed with different BMP 
antisera. A: Tissue extracts from olfactory bulbs (lane 1, 6: postnatal day [P] 10; lane 2, 7: P17; lane 3,8: adult) and 
from olfactory epithelium (lane 4: P10; lane 5: adult) probed with anti-BMP6 (lanes 1–5) or with the antiserum 
pretreated with the appropriate peptide to block immunoreactivity (lanes 6 – 8). B: Tissue extracts from adult olfactory 
bulbs (lanes 1, 3) or from olfactory epithelia (lane 2, 4) probed with anti-BMP4 (lanes 1, 2) or with the antiserum 
blocked with the appropriate BMP4 peptide (lanes 2, 4). C: Tissue extracts from P17 olfactory bulbs probed with anti-
BMP7 (lane 1) or with the antiserum blocked with its peptide (lane 2).
BMP4 localization changes duringdevelopment
From E15.5 to E17.5, a diffuse BMP4 immunoreactivity (-ir) was identified in connective tissue 
around the developing OB and below the OE in the lamina propria (data not shown). At E19.5, 
BMP4 immunostaining was less pronounced in the connective tissue and became visible in the 
developing OB, where it was identified in the olfactory nerve layer, glomerular layer, in the SVZ 
and in the emerging granule cell layer that surrounds the olfactory ventricle (Fig. 2C). Nonspecific 
staining was present along the mucus/cilia layer of the olfactory epithelium and in the meninges 
surrounding the OB (see Fig. 2C,D). This staining, visible in sections processed with and without 
primary antisera, was attributed to background. At this age, in situ hybridization with the BMP4 
antisense probe labeled cells in the OE and in the mitral cell layer of the OB (Fig. 2A), illustrating 
the presence of BMP4 mRNA in ORN and mitral cell populations. Incubation with the BMP4 sense 
probe gave only background levels of hybridization, confirming the specificity of the analysis (Fig. 
2B).
During the first postnatal week (P1–P7), BMP4-ir was particularly evident in the glomerular layer 
of the OB, where glomeruli were seen as intensely labeled globular 
structures (Fig. 2D). Strong immunostaining was also observed in the outer part of the internal 
plexiform layer and in the mitral cell layer, whereas the olfactory nerve layer and the external 
plexiform layer were less intensely stained. BMP4 expression was also identified in the SEL, which
represents the remnant of the embryonic SVZ (see Fig. 2D).
The pattern of BMP4-ir at postnatal day (P) 14 resembled that seen at P7. At this stage, the 
immunostaining in the SEL was more intense and appeared in a web-like distribution (Fig. 2E). In 
adult animals, BMP4-ir was completely absent from the internal and external plexiform layers and 
very faint in the olfactory nerve and glomerular layers. Strong BMP4 immunostaining persisted, 
however, in the SEL (Fig. 2F). As in the Western blots, preincubation of the anti-BMP4 with the 
immunogenic peptide (10 μM) completely abolished the immunoreactivity, confirming the 
specificity of the staining (data not shown).
Fig. 2. Distribution of bone morphogenetic protein-4 (BMP4) mRNA and BMP4 immunoreactivity (-ir) in the olfactory 
system during development. Adjacent sections of an embryonic day (E) 19.5 olfactory system treated for in situ 
hybridization by using antisense BMP4 probe (A) and sense probe (B). A: In the olfactory epithelium (oe), labeled cells 
are visible in all neuronal layers of the epithelium, whereas BMP4 mRNA expression is restricted to the mitral cell layer
(m) of the bulb. B: Use of the BMP4 sense probe resulted in background levels of hybridization only, confirming the 
probe specificity. C–F: Coronal sections of mouse OB immunostained with anti-BMP4 antisera. C: At E19.5 BMP4-ir is
localized to connective tissue around the developing olfactory bulb (OB), in the olfactory nerve layer (onl), and in the 
emerging glomerular layer (gl). Labeling in the subventricular zone (SVZ) surrounding the olfactory ventricle is also 
visible. D: At postnatal day (P) 7, immunostaining is widely distributed in different OB layers: stronger in the glomeruli
(gl) and in the internal plexiform layer (ip), weaker in the onl, and in the external plexiform layer (ep). The dotted line 
in C and D indicate the SVZ/SEL area. SEL, subependymal layer. E: At P14, BMP4-ir distribution is similar to that seen
at P7, moreover strong immunostaining in the SEL appears. F: In the adult, the staining is restricted to the SEL; some 
endothelial cells around blood vessels are also immunopositive. Section thickness = 8 μm in A,B, 35 μm in C, 10 μm in 
D–F. Scale bar in A = 200 μm in A,B, 100 μm in C, 125 μm in D,E, 50 μm in F.
BMP7 is expressed in olfactory nerves, the
glomerular layer, and SVZ/SEL
The patterns of BMP4-ir and BMP7-ir were very similar during the early development of the 
olfactory system. From E15.5 to E17.5 BMP7 immunostaining was found primarily in regions of 
connective tissue around the bulb and, at E17.5, faint staining was also visible in tissue surrounding 
the olfactory ventricle (Fig. 3A). At E19.5 and P2 BMP7-ir was still present, but less intense, in 
areas of connective tissue, whereas stronger immunostaining was identified in cells located in the 
external part of the SVZ. At these perinatal ages, BMP7-ir began to appear in the developing 
glomerular layer (Fig. 3B). From P21 to adult-hood, BMP7-ir was evident in the olfactory nerve 
and glomerular layers. Intense immunoreactivity for BMP7 was also observed in the SEL (Fig. 3C).
Like BMP4 immunostaining, BMP7-ir within the SEL exhibited a mesh-work appearance with no 
clearly distinguishable stained cell bodies. As seen with BMP4-ir, nonspecific staining was found in
the mucus/cilia layer of the OE and in the meninges surrounding the OB (Fig. 3A, B).
Fig. 3. Bone morphogenetic protein-7 (BMP7) immunoreactivity (-ir) in the olfactory bulb at different ages. A,B,C: 
Coronal sections. A: At embryonic day (E) 17.5, BMP7 immunostaining is visible in the connective tissue around the 
bulb (ob) and in cells of the subventricular zone (SVZ) within the bulb. B: At postnatal day (P) 2, BMP7-ir is similar to 
that observed for BMP4 in perinatal age (see Fig. 2C), i.e., connective tissue around the bulb, olfactory nerve layer 
(onl), glomerular layer (gl), and postnatal SVZ are stained. C: In the adult, BMP7-ir is still present in the onl and gl and 
is also localized strongly in the SEL and very weakly in the mitral cell layer. The dotted lines in A and B indicate the 
SVZ/subependymal layer region. Section thickness ϭ 35 μm in A–C. Scale bar in A ϭ 100 μm in A,B, 50 μm in C.
Fig. 4. Immunoreactivity for bone morphogenetic protein-7 (BMP7) or BMP4 and other markers in the subependymal 
layer (SEL) of adult olfactory bulb. Coronal sections. A–C: Double immunostaining for BMP7 and glial fibrillary acidic
protein (GFAP). C: In the simultaneous view of BMP7 immunoreactivity (-ir) and GFAP-ir, only a partial overlap is 
detectable. D: A simultaneous view of BMP4-ir and GFAP-ir reveals a pattern of overlap that is similar to BMP7/GFAP 
immunostaining. E–G: Double immunostaining for BMP7 and PSA-NCAM. G: The simultaneous view of BMP7-ir and
PSA-NCAM–ir shows no overlap of expression. H: Similarly, no overlap is observed in the simultaneous view of 
BMP4-ir and PSA-NCAM–ir. The similarity in overlap between BMP4 and 7 and these neuronal and glial markers 
concurs with our observation that BMP4 and BMP7 share the same expression pattern. Scale bars ϭ 50 ␮m in C 
(applies to A–C), in D, in G (applies to E–G), in H.
Which component of the SEL expresses BMP4/7?
Strong BMP4 and BMP7 immunostaining appeared in the SEL of the P14 olfactory bulb. Because 
the antisera for BMP4 and BMP7 were produced in the same species, double-labeling 
immunostaining was not conducted. Examination of coronal sections from rostral forebrain showed 
that, within the SEL, the immunoreactivity for BMP4 and BMP7 had very similar times of onset 
and a meshwork-like distribution (see Figs. 2F, 3C). Therefore, we will refer to this immunostaining
as BMP4/7-ir in the SEL. To identify the SEL cellular compartment labeled by BMP4/7-ir, double 
immunostaining with GFAP (marker of the astrocytic component) and PSA-NCAM (marker for the 
migrating cells) was performed (see Fig. 4). Image analysis of the double labeling was carried out 
with confocal microscopy by (1) examining the sum of optical sections scanned through a 10-μm 
thickness (as in Fig. 4C,G), or by (2) examining single 1-μm optical sections (as in Fig. 4D,H). The 
results obtained by using these two methods appeared comparable. Double immunostaining for 
GFAP and BMP4 or BMP7 revealed an overlap in the glial meshwork (Fig. 4C,D). The overlap was
only partial, however, and at higher magnification it was possible to observe that the BMP4-ir or 
BMP7-ir was often at the edge of GFAP-immunopositive processes. This distribution was detected 
all along the SEL from the lateral ventricle to the olfactory bulb. Double immunolabeling with 
PSA-NCAM and BMP4 or BMP7 revealed no overlap in any regions of the SVZ at any age 
examined (Fig. 4G,H). However, the meshwork-like BMP4/7 immunostaining among the PSA-
NCAM–positive cells was very evident in the SEL of the OB.
BMP6 is restricted to the olfactory nerve and glomeruli
During development, BMP6-ir is present in the OE from E15.5 to adulthood in the upper third of 
the OE and in the axon bundles coursing through the lamina propria toward the OB (see Fig. 5A). 
From E15.5 to E17.5, BMP6-ir was visible in the olfactory nerve and nerve layer of the OB. At 
E17.5 in the OE region, strong staining was observed in association with axon bundles below the 
mucosa (Fig. 5A). At E19.5, the antisense probe for BMP6 hybridized to the most superficial 
olfactory receptor neurons in the epithelium (Fig. 5C), indicating that BMP6 mRNA is present in 
these cells. Incubation of adjacent sections with the BMP6 sense probe resulted in background 
levels of hybridization (Fig. 5D).
After birth, BMP6 immunostaining in the bulb was found in the emerging glomerular layer as well 
as in the olfactory nerve layer. In these layers, strong BMP6-ir was observed in early postnatal 
olfactory bulb tissue, e.g., at P7 (Fig. 5E); however, by adulthood, some glomeruli exhibited more 
intense levels of immunostaining than others (Fig. 5F). Incubation of tissue sections with BMP6 
antisera preabsorbed with the appropriate immunogenic peptide (10 ␮M) completely abolished the 
immunoreactivity leaving only some nonspecific staining in cartilage (see Fig. 5B).
Fig. 5. Distribution of bone morphogenetic protein-6 (BMP6) immunoreactivity and BMP6 mRNA. A,B: Adjacent 
sections of an embryonic day (E) 17.5 olfactory system treated with anti-BMP6 antiserum (A) or with the antiserum 
absorbed with its peptide (B). A: Arrows indicate BMP6-ir in the olfactory nerves surrounding the bulbs (ob) and in the 
axon bundles below the olfactory epithelium (oe). The subventricular zone (SVZ) in the bulb is also weakly stained. B: 
In preabsorbed control sections, immunostaining in the axon bundles, nerve layer, and glomerular layer is blocked. 
Nonspecific immunoreactivity remains around cartilage and in the vomeronasal organ. C,D: E19.5 adjacent coronal 
sections of olfactory epithelium treated for in situ hybridization with antisense (C) and sense probes (D). C: BMP6-
mRNA expression is visible in olfactory receptor neurons in the most superficial layer of the epithelium. D: In tissue 
treated with the sense probe, no hybridization is present. E,F: BMP6-ir in coronal sections of olfactory bulb. E: At 
postnatal day 7, a strong immunostaining is evident in the olfactory nerve layer (onl) and in all glomeruli (gl). F: In the 
adult olfactory bulb, the staining appeared to decrease in intensity. In the gl, BMP6-ir exhibits a patchy distribution: 
some glomeruli show stronger immunostaining (arrows) than others. Section thickness = 35 ␮m in A,B,F, 8 μm in C,D, 
10 μm in E. Scale bar in F = 225 μm in A,B, 100 μm in C,D, 65 μm in E,F.
BMP6-ir is predominantly colocalized with OMP-ir
To identify which component(s) of the OE express BMP6, we performed double 
immunofluorescence reactions with BMP6 and GAP43 (a marker for immature ORNs; Verhaagen et
al., 1989; Schwob et al., 1992) or OMP (a marker for mature ORNs; Margolis, 1972) in the OE and 
OB of young adult mice. Double immunostaining with BMP6 (Fig. 6A,D) and GAP43 (Fig. 6B,E) 
antisera revealed a minimal overlap; only a few dendrites extending from GAP43-immunopositive 
neurons, and some rare cell bodies (arrow, Fig. 6F), appeared double labeled (Fig. 6C,F). 
Furthermore, there appeared to be incomplete overlap in BMP6-ir and GAP43-ir between axons 
coursing through the large nerve bundles (Fig. 6C,F). Double immunofluorescence with BMP6 and 
OMP antisera showed a more extensive overlap of OMP and BMP6 in the nerve bundles compared 
with that seen in sections double-labeled for BMP6 and GAP43 (Fig. 6C,I). In addition, many 
neurons double-labeled for BMP6 and OMP were present in the upper third of the OE (Fig. 6I,L), 
and strong BMP6-ir was found in the most superficial part of the epithelium corresponding to the 
sustentacular cell layer. These data suggest that BMP6 is expressed in mature ORNs, their apical 
dendrites, and perhaps sustentacular cells.
In the OB, BMP6-ir was expressed in the olfactory nerve and glomerular layers (Fig. 7A,D). Dual 
labeling with BMP6 and GAP43 antisera was observed in the olfactory nerve layer and in a few 
discrete regions within glomeruli (Fig. 7A–C). These foci were concentrated mostly in the caps of 
the glomeruli, where olfactory axons enter, and around the edges. In the OB, BMP6 and OMP 
expression patterns were very similar, both appeared homogeneously distributed in the olfactory 
nerve layer and throughout the glomerular layer (Fig. 7D–F). The overlap of BMP6-ir and OMP-ir 
was almost complete, although BMP6-ir appeared more intense around the edges of glomeruli 
compared with the center (Fig. 7D). This observation is interesting and may relate to the 
compartmental organization of the olfactory glomerulus that has been observed with other markers 
(Kosaka et al., 1998; Kasowski et al., 1999). In addition, some axons in the olfactory nerve layer 
stained positively for either OMP or BMP6 alone. This result concurs with our observation in the 
axon bundles of the epithelium (see Fig. 6I) and indicates heterogeneity of coexpression of OMP 
and BMP6. All the results regarding the expression and distribution of BMP4, 6, and 7 mRNA and 
protein are summarized in Table 1.
DISCUSSION
In this study, we have analyzed the expression of BMP4, 6, and 7 mRNA and protein in the mouse 
olfactory system during embryonic and postnatal development and in adulthood. BMPs represent a 
subclass of ligands of the TGFβ superfamily of cytokines that exhibit a multitude of biological 
effects during development and regeneration. We focused our attention on the olfactory system, 
because it retains a high degree of neural plasticity throughout life both in the OE (where ORNs can
be continuously replaced) and in the OB (where olfactory glomerular reorganization and protracted 
neurogenesis occurs). Our results demonstrate a precise spatial and temporal expression of these 
cytokines in both the OE and OB. These data are consistent with the growing literature regarding 
the multitude of roles played by BMPs in regulating mechanisms of neurogenesis, differentiation, 
and rearrangement of neural synaptic circuits in the embryonic CNS and in particular areas of the 
adult brain.
BMP4 and BMP7 in the olfactory mucosa and in the OB
Although BMP4 and 7 are considered members of separate subgroups of BMPs (Kingsley, 1994) 
and double-immunofluorescence experiments were not performed because both the antibodies were 
raised in the same donor species, our data show that, in the olfactory system, these proteins share 
similar patterns of expression during embryonic and postnatal life. Our in situ hybridization and 
immunohistochemical analyses demonstrate that the changes in BMP4 and 7 localization during 
development occur in parallel. In the early stages of embryonic development, a diffuse 
immunoreactivity for these secreted factors was identified in the connective tissue around the 
developing OB and below the OE (see Fig. 3A). At E19.5, ISH showed that BMP4 mRNA is 
present in the OE and in the MCL of the olfactory bulb. At this same age, BMP4 and 7 
immunostaining became evident in the olfactory bulb nerve layer (ONL) and in the forming 
glomerular layer (GL). These data suggest that, during embryonic development, both ORNs and 
mitral cells can produce and transport these proteins along their neuritic processes.
The presence of BMP4 and 7, together with BMP6 (see below), suggests a role for these factors in 
the ontogenesis of the OE. This suggestion is further supported by two recent studies (Shou et al., 
1999, 2000) demonstrating that BMP2, 4, and 7 are expressed in the embryonic OE region. In vitro, 
high concentrations of BMP2, 4, or 7 inhibit neurogenesis by acting on an early stage progenitor in 
the ORN lineage by means of inactivation of the transcription factor MASH-1 (Shou et al., 1999), 
which is required for ORN production in vivo (Guillemot and Joyner, 1993). On the other hand, at 
concentrations below the threshold for inhibition of neurogenesis, BMP4 increases neurogenesis by 
promoting the survival of newly generated ORNs (Shou et al., 2000).
As noted above, the pattern of BMP-ir changes during the first postnatal days of life. In particular, 
between P1 and P7, we found an increase of BMP4 and 7 in the olfactory glomeruli and a 
concomitant reduction of immunoreactivity in the ONL. This temporal rise of BMP-ir in the 
olfactory glomeruli suggests an involvement of these proteins in processes regulating the axonal 
targeting of ORNs and glomerular maturation. Indeed, it is interesting to note that olfactory axons 
coalesce into glomeruli before birth; however, the MC apical dendrites initially arborize over 
several glomeruli during the first postnatal week of life and then become restricted to individual 
glomeruli (Malun and Brunjes, 1996; Bailey et al., 1999). The rearrangements of the MC dendrites 
and the subsequent synaptic stabilization between these dendrites and the ORN axons might be 
driven by the activity of secreted factors such as the BMPs. The involvement of BMPs and their 
receptors in the process of dendritic formation and maturation is well documented in other systems 
(Lein et al., 1995; Le Roux et al., 1999; Withers et al., 2000). In particular, Withers and colleagues 
working on cultures of hippocampal neurons demonstrated that BMP7 acts as a growth factor 
selective for dendritic development. Addition of BMP7 to cultured hippocampal neurons results in a
rapid and profound acceleration of dendritic growth and enhances synaptogenesis. Since the 
presence of BMPs and their receptors have been described in vivo in the adult hippocampus and OB
(Charytoniuk et al., 2000), regions where the dendritic arbor continues to be remodeled throughout 
life (Graziadei and Monti Graziadei, 1979; Stanfield and Trice, 1988), these authors suggest a role 
for BMP7 in modulating this type of plasticity. Furthermore, enhancement of dendritic growth due 
to the BMPs has been demonstrated for sympathetic (Lein et al., 1995) and cerebral cortical (Le 
Roux et al., 1999) neurons.
Our results, showing a precise temporal and spatial expression of BMP4 and 7, are consistent with a
possible involvement of these secreted proteins in mechanisms regulating the glomerular synaptic 
organization both during ontogenesis and adulthood. These reports are consistent with our results 
showing (1) the presence of BMP4 and 7 in the olfactory bulb glomerular layer from the early post-
natal period to adulthood, and (2) a peak of expression of these proteins in the olfactory glomeruli 
during the first weeks of postnatal life, concomitant with extensive remodeling of the mitral cell 
dendritic arbors. In fact, the synaptic contacts between the axons of ORNs and dendrites of mitral 
and tufted cells are capable of being remodeled throughout life.
Finally, the decrease of BMP immunoreactivity in the ONL observed during the early postnatal 
period could indicate that, at this stage, the mitral cells are the principal source of BMP7 and 4. 
Alternatively, these proteins may be produced by the ORNs with subsequent transport along their 
axons and release at the level of the presynaptic terminals, as are some neurotrophins (Altar and 
DiStefano, 1998). This latter possibility is also supported by our Western blot data, indicating 
persistence of BMP4 in the OE region of adult animals. Evaluation of these alternatives awaits 
analysis of BMP secretion patterns.
Fig. 6. Immunoreactivity for bone morphogenetic protein-6 (BMP6) and other antigens in olfactory epithelium of a 
postnatal day 21 mouse (coronal sections). A–F: Double immunostaining of BMP6/ GAP43. GAP43, growth associated 
protein 43. G–L. Double immunostaining of BMP6/OMP. OMP, olfactory marker protein. C,F,I,L: Simultaneous views 
of BMP6 immunoreactive (-ir) and GAP43-ir (C,F) and of BMP6-ir and OMP-ir (I,L) illustrate the partial overlap of 
BMP6/GAP43 expression and the greater overlap of BMP6/OMP expression. s, sustentacular cell layer; ax, olfactory 
axons. Scale bars = 50 μm in C (applies to A–C), in F (applies to D–F), in I (applies to G–I), in L (applies to J–L).
Fig. 7. Immunoreactivity for bone morphogenetic protein-6 (BMP6) and other antigens in the olfactory bulb of a 
postnatal day 21 mouse (coronal sections). A–F: Dual labeling for BMP6/GAP43 (A–C), and for BMP6/OMP (D–F). 
GAP43, growth associated protein 43; OMP, olfactory marker protein. C: Simultaneous view of BMP6 
immunoreactivity (-ir) and GAP43-ir shows that these antigens are both expressed along the olfactory nerve (onl) but 
are not colocalized in glomeruli (gl). F: Simultaneous view of BMP6-ir and OMP-ir demonstrates complete overlap in 
these expression patterns. Scale bar = 50 μm in F (applies to A–F).
TABLE 1. BMPs Distribution in the Olfactory System 1
1Identification of bone morphogenetic protein 4 (BMP4), BMP7, and BMP6 in the olfactory system of prenatal (E15.5–
E19.5), postnatal (P1–P14), and young/adult (P30 –P90) mice. Because BMP4 and BMP7 share similar patterns of 
localization, they were reported in the same tab. These results were obtained by using immunocytochemistry (ICC), in 
situ hybridization (ISH), and Western blot (wb) analysis. For details see the text. OE, olfactory epithelium; OS, 
olfactory submucosa; ONL, olfactory nerve layer; GL, glomerular layer; EPL, external plexiform layer; ML, mitral cell 
layer; IPL, internal plexiform layer; GRL, granule cells layer; SVZ/SEL, subventricular zone/subependymal layer.
2Related to BMP4.
3Related to BMP7.
BMP4/7 expression in the SVZ/SEL of mice
We have identified BMP4-ir and BMP7-ir in the germinative SVZ within the embryonic OB 
beginning as early as E19.5. These observations are in agreement with several in vivo and in vitro 
studies showing that BMPs and their receptors are present in the embryonic ventricular and 
subventricular germinal zones where they play temporal and spatial-specific roles in modulating the
proliferation, survival, and differentiation of the neural precursor cells. BMP2, 4, 6, 7, and 13 
inhibited cell proliferation and promoted neuronal differentiation of neocortical precursors in the 
VZ (Li et al., 1998). BMP4 and 7, and BMP receptors are expressed in the SVZ precursor cells. The
addition of BMP2, 4, 6, or 7 to cultured, dissociated SVZ precursor cells resulted in astroglial 
lineage commitment (Gross et al., 1996). We have demonstrated strong expression of BMP4 and 7 
in the postnatal and adult SEL. This region is interposed between the lateral ventricles and the OB 
and originates during the first days of postnatal life from the SVZ after the occlusion of the 
olfactory ventricle (Boulder Committee, 1970). The SEL of adult rodents shows an interesting 
organization (glial tubes and chains of migrating newly formed cells) and is considered the source 
of the newly generated neuroblasts of the OB (Luskin, 1993; Lois and Alvarez-Buylla, 1994; 
Peretto et al., 1999). During postnatal life, the expression of BMP4/7 within the SEL of the OB 
increases, and from approximately P14, a web-like distribution, resembling glial tubes, can be 
recognized.
It is interesting to note that, in the SEL of neonatal rats, neither glial tubes nor chains of migrating 
neuroblasts are detectable before the end of the second postnatal week of life (personal 
observations). Moreover, in adults, double immunostaining for BMP4 and 7 with markers for both 
the glial tubes and migrating neuroblasts showed that these cytokines are not associated with one 
specific SEL component (see Fig. 4). However, dual labeling with BMP4/7 and GFAP antibodies 
indicated a partial colocalization among the astrocytic cells of the glial tubes (see Fig. 4C,D). Taken
together, these data support our hypothesis that BMP4/7 is secreted by SEL glia as early as the 
second week of postnatal life, when the typical adult compartmentalization occurs in this region. 
This postulated secretion of BMPs by the astrocytic glia within the SEL suggests that BMP4/7 
participate in the regulation of adult neurogenesis, which is consistent with different studies 
showing the presence of BMPs and their receptors in the SEL region, and that the glial tubes can 
secrete extracellular matrix molecules that may also be involved in regulating proliferation, 
migration, differentiation, and fate of the SEL neuroblasts (Gates et al., 1995; Jankovski and Sotelo 
1996; Coskun et al., 2001; Lim et al., 2000). It is noteworthy that Lim et al., 2000, have 
demonstrated that the activity of the BMPs in the SEL of the lateral ventricle is modulated by the 
action of noggin, one of their natural antagonists, which is secreted by the ependymal cells lining 
the ventricles. Their concomitant action creates a niche for adult neurogenesis. Ongoing studies are 
needed to elucidate the role of BMPs in the most anterior parts of the SEL and the possible presence
of antagonists or modulatory factors.
BMP6 expression in the OE and OB
The first occurrence of BMP6 in the OE was identified at E15.5, and high levels of expression in 
this area and in the OB are preserved into adulthood. Both mRNA and protein expression were 
found in the upper third of the olfactory mucosa. BMP6-ir was also identified in axon fascicles 
below the mucosa and coursing toward the OB, suggesting that mature ORNs express BMP6. This 
suggestion was further confirmed in adult animals by double immunostaining for BMP6 and 
specific markers for immature and mature ORNs (see Figs. 6, 7). A strong colocalization between 
BMP6-ir and OMP-ir was found in the OE and OB. OMP is expressed only by mature olfactory 
receptor cells and is present in their perikarya, dendrites, axons, and terminals in the OB (Margolis, 
1972; Graziadei et al., 1980; Farbman and Margolis, 1980). Whereas a partial colocalization 
between BMP6 and GAP43 (a marker for immature ORNs) was found in the olfactory axon bundles
located below the olfactory mucosa and within the ONL, only a few double-immunopositive 
BMP6/GAP43 ORNs were observed in the OE. These data confirm that BMP6 is primarily 
associated with mature ORNs and suggests A role for this protein in the process of maturation of the
ORNs, e.g., the switch from GAP43 to OMP expression. As described for BMP4 and 7, the 
persistence of BMP6-ir in the OE and in the OB glomeruli might be also related to synaptic 
regulation of the olfactory glomerular circuits.
In conclusion, the patterns of distribution of BMP4, 6, and 7 in the OE and bulb described in this 
study support the idea that these factors play a role in the morphogenesis of the olfactory system 
both during development and during the regenerative activity present in adult animals. Within this 
context, it is particularly intriguing to consider the roles played by several BMP antagonists such as 
noggin, a putative modulator of neurogenesis and specification (McMahon et al., 1998; Lim et al., 
2000). Future studies will be directed at ascertaining the postulated roles of these proteins in 
olfactory system plasticity, particularly in the functional organization of the olfactory glomeruli.
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